CD4 and neoplasm: Despite containing a high abundance of immune cells, including CD8+ T, CD4+ T, and natural killer (NK) cells inside, and being considered “immune-inflamed” or “hot” tumors, many GC and CRC patients show resistance to ICIs, similar to immunosuppressive tumor types55–58.